<DOC>
	<DOCNO>NCT02106767</DOCNO>
	<brief_summary>The effect transporter inhibition rifampin pharmacokinetics rosuvastatin studied clinical trial White Asian healthy volunteer .</brief_summary>
	<brief_title>The Effects Rifampin Pharmacokinetics Rosuvastatin</brief_title>
	<detailed_description />
	<mesh_term>Rifampin</mesh_term>
	<mesh_term>Rosuvastatin Calcium</mesh_term>
	<criteria>Healthy Asian volunteer HanChinese/Japanese/Korean descent whose parent grandparent HanChinese/ Japanese/ Korean . Healthy Caucasian volunteer White/Caucasian/Europeanborn descent whose parent grandparent White/Caucasian/European . Male female , ages 1865 year old , current medical condition active diagnosis determine study doctor base history , physical exam , laboratory evaluation . Subjects take medication two week prior study time course study include prescription medication , overthecounter medication , dietary supplement , drug abuse . Subjects follow genotype : SLCO1B1*1a ABCG2 421CC . Subjects able maintain adequate birth control study independent hormonal contraceptive use . Subjects able abstain grapefruit , grapefruit juice , orange , orange juice , caffeinated beverage and/or alcoholic beverage 7am day study completion study day . Participants determine normal liver kidney function measure baseline BMI 18.0 30 kg/m2 Subjects capable fast food beverage least 8 hour prior medication dosing . Be able read , speak , understand English . Subjects capable provide informed consent completing requirement study . Subjects active medical problem Subjects chronic prescription OTC medication stop 2 week prior study . Subjects incapable multiple blood draw ( HCT &lt; 30mg/dL ) Subjects history rhabdomyolysis Subjects history drugrelated myalgias Subjects history diagnosis hemorrhagic tendency blood dyscrasias Subjects history GI bleed peptic ulcer disease Subjects smoke tobacco ongoing alcohol illegal drug use Subjects pregnant , lactating , try conceive study period Subjects allergic rosuvastatin rifampin know component medication Anyone opinion study investigator unable study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>December 2015</verification_date>
	<keyword>rosuvastatin</keyword>
	<keyword>rifampin</keyword>
	<keyword>pharmacokinetics</keyword>
	<keyword>drug interaction</keyword>
	<keyword>healthy volunteer</keyword>
	<keyword>drug transporter</keyword>
	<keyword>Asian</keyword>
	<keyword>White</keyword>
</DOC>